Ying Y, Yahya N, Manan HA (2024) Amide proton transfer MR imaging in the characterization of brain tumors: a review paper. J Radiat Res Appl Sci 17(3):101043
Nguyễn-Hoàng T et al (2024) Discriminating glioblastoma from normal brain tissue in vivo using optical coherence tomography and angiography: a texture and microvascular analysis approach. Photonics 11:435
Babi A et al (2022) Targeting heat shock proteins in malignant brain tumors: from basic research to clinical trials. Cancers (Basel). 14(21):5435
Article CAS PubMed PubMed Central Google Scholar
Pham T-N et al (2024) Early effects of different brain radiotherapy modalities on circulating leucocyte subpopulations in rodents. Int J Radiat Biol 100(5):744–755
Article CAS PubMed Google Scholar
Ebrahimi N, Far NP, Fakhr SS, Faghihkhorasani F, Miraghel SA, Chaleshtori SR, Rezaei-Tazangi F, Beiranvand S, Baziyar P, Manavi MS, Zarrabi A (2023) The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma. Environ Res. 1(228):115914
Goto Y et al (2017) The emerging roles of the ubiquitination/deubiquitination system in tumor radioresistance regarding DNA damage responses, cell cycle regulation, hypoxic responses, and antioxidant properties: Insight into the development of novel radiosensitizing strategies. Mutat Res 803–805:76–81
Graner MW, Bigner DD (2005) Chaperone proteins and brain tumors: Potential targets and possible therapeutics. Neuro-Oncol 7(3):260–278
Article CAS PubMed PubMed Central Google Scholar
Burko P et al (2023) Molecular pathways implicated in radioresistance of glioblastoma multiforme: what is the role of extracellular vesicles? Int J Mol Sci 24(5):4883
Article CAS PubMed PubMed Central Google Scholar
Moreno JA, Tiffany-Castiglioni E (2015) The chaperone Grp78 in protein folding disorders of the nervous system. Neurochem Res 40(2):329–35
Article CAS PubMed Google Scholar
Iglesia RP et al (2019) Heat shock proteins in glioblastoma biology: where do we stand? Int J Mol Sci. 20(22):5794
Article CAS PubMed PubMed Central Google Scholar
Hasan A et al (2022) Molecular chaperones in DNA repair mechanisms: role in genomic instability and proteostasis in cancer. Life Sci 306:120852
Article CAS PubMed Google Scholar
Ellingson BM et al (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro Oncol 17(9):1188–98
PubMed PubMed Central Google Scholar
Molina ML et al (2022) Chaperone-mediated autophagy ablation in pericytes reveals new glioblastoma prognostic markers and efficient treatment against tumor progression. Front Cell Dev Biol 10:797945
Article PubMed PubMed Central Google Scholar
Holmberg Olausson K et al (2015) NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape. Sci Rep 5(1):16495
Article CAS PubMed PubMed Central Google Scholar
Romani M, Pistillo MP, Banelli B (2018) Epigenetic targeting of glioblastoma. Front Oncol 8:448
Article PubMed PubMed Central Google Scholar
McClellan BL et al (2023) Impact of epigenetic reprogramming on anti-tumor immune responses in glioma. J Clin Invest 133(2):e163450
Article CAS PubMed PubMed Central Google Scholar
Wee P, Wang Z (2017) Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel) 9(5):52
Oldrini B et al (2020) MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas. Nat Commun 11(1):3883
Article PubMed PubMed Central Google Scholar
Bikfalvi A et al (2023) Challenges in glioblastoma research: focus on the tumor microenvironment. Trends Cancer 9(1):9–27
Article CAS PubMed Google Scholar
Tripathy DK et al (2024) Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches. Front Pharmacol 15:1355242
Article CAS PubMed PubMed Central Google Scholar
Bascos NAD, Landry SJ (2019) A history of molecular chaperone structures in the protein data bank. Int J Mol Sci. 20(24):6195
Article CAS PubMed PubMed Central Google Scholar
Cortez L, Sim V (2014) The therapeutic potential of chemical chaperones in protein folding diseases. Prion 8(2):197–202
Article CAS PubMed PubMed Central Google Scholar
Ciechanover A, Kwon YT (2017) Protein quality control by molecular chaperones in neurodegeneration. Front Neurosci 11:185
Article PubMed PubMed Central Google Scholar
Chakraborty A, Edkins AL (2023) CHIP: a Co-chaperone for degradation by the proteasome and lysosome. Subcell Biochem 101:351–387
Article CAS PubMed Google Scholar
Tran ML et al (2020) Second-generation pharmacological chaperones: beyond inhibitors. Molecules 25(14):3145
Article CAS PubMed PubMed Central Google Scholar
Diamant S et al (2001) Chemical chaperones regulate molecular chaperones in vitro and in cells under combined salt and heat stresses. J Biol Chem 276(43):39586–91
Article CAS PubMed Google Scholar
Kushwah N, Jain V, Yadav D (2020) Osmolytes: a possible therapeutic molecule for ameliorating the neurodegeneration caused by protein misfolding and aggregation. Biomolecules 10(1):132
Article CAS PubMed PubMed Central Google Scholar
Rösge J (2007) Chapter twenty-six - molecular basis of osmolyte effects on protein and metabolites. In: Häussinger D, Sies H (eds) Methods in enzymology. Academic Press, pp 459–486
Kim SH, Yan YB, Zhou HM (2006) Role of osmolytes as chemical chaperones during the refolding of aminoacylase. Biochem Cell Biol 84(1):30–8
Article CAS PubMed Google Scholar
Sinnige T, Yu A, Morimoto RI (2020) Challenging proteostasis: role of the chaperone network to control aggregation-prone proteins in human disease. Adv Exp Med Biol 1243:53–68
Article CAS PubMed PubMed Central Google Scholar
Sharma A et al (2023) Molecular chaperones as therapeutic target: hallmark of neurodegenerative disorders. Mol Neurobiol 61(7):4750–4767
Bose S, Cho J (2017) Targeting chaperones, heat shock factor-1, and unfolded protein response: promising therapeutic approaches for neurodegenerative disorders. Ageing Res Rev 35:155–175
Article CAS PubMed Google Scholar
Mamipour M, Yousefi M, Hasanzadeh M (2017) An overview on molecular chaperones enhancing solubility of expressed recombinant proteins with correct folding. Int J Biol Macromol 102:367–375
Comments (0)